Juniper Pharmaceuticals Reports Results from Phase 2b Clinical Trial of COL-1077 Lidocaine Vaginal Gel in Gynecologic Procedure Pain

BOSTON, Aug. 17, 2016 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ( " Juniper " or the " Company " ), a women ' s health therapeutics company, today announced that a recently completed Phase 2b clinical trial evaluating its 10% lidocaine...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials